International medical cannabis sales exceed those in Canada, CEO says cannabis revenue has picked up amid global pandemic. In a statement, Chief Executive Brendan Kennedy said ... the company took several steps to make its business more efficient, which should save it $40 million a year, though the measures were not “fully reflected” in the first quarter’s results. The company sold $5.8 million worth of medical weed abroad, which was higher than medical sales in Canada for the first time. “International medical will never go back,” Kennedy said in the earnings call. “It will always be in excess of our Canadian medical revenue.”
Brendan Kennedy was an early mover in the market as the world started to legalise cannabis. It seemed like a crazy and risky decision a decade ago. Now, he's sitting on a fortune, Jane Lewis reports. When Brendan Kennedy gave up his job in finance to gamble on the commercial potential of legal cannabis, everyone thought he was crazy. Nine years on, he has become "a poster child of the green rush", says The Times. He presides over Tilray, a self-described "global leader in cannabis research, cultivation, processing and distribution", which has ridden "an extraordinary global surge towards legalisation".